Mrs Dana Sue Livingston, RPH is a
Pharmacist based in East Alton, Illinois. Mrs Dana Sue Livingston is licensed to practice in Illinois (license number 051-287430) and her current practice location is
550 W Saint Louis Ave, East Alton, Illinois. She can be reached at her office (for appointments etc.) via phone at
(618) 258-0350.
NPI number for Mrs Dana Sue Livingston is 1114202280 and her current mailing address is 310 Doerr St, Roxana, Illinois. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1114202280.
Healthcare Provider's Profile
Full Name | Mrs Dana Sue Livingston |
---|
Gender | Female |
---|
Speciality | Pharmacist |
---|
Location | 550 W Saint Louis Ave, East Alton, Illinois |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1114202280
- Provider Enumeration Date: 10/19/2011
- Last Update Date: 10/19/2011
Medical Identifiers
Medical identifiers for Mrs Dana Sue Livingston such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1114202280 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 34475 (Texas) | Secondary |
183500000X | Pharmacist | 051-287430 (Illinois) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Dana Sue Livingston is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Mrs Dana Sue Livingston, RPH 310 Doerr St, Roxana, IL 62084-1114 Ph: (618) 251-9195 | Mrs Dana Sue Livingston, RPH 550 W Saint Louis Ave, East Alton, IL 62024-1044 Ph: (618) 258-0350 |
Reviews and Comments